Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Quality Index

Latest as of September 2024: 3.74x

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. cash flow quality index. Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow Quality Index of 3.74x as of September 2024. Operating cash flow of TL33.37 Million exceeds net income of TL8.93 Million, indicating high earnings quality where cash backs reported profits. See ONCSM FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

3.74x
Operating CF / Net Income

Operating Cash Flow

TL33.37 Million
TRY

Net Income

TL8.93 Million
TRY

Data as of

Sep 2024
Most recent filing

Cash Flow Quality Index of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2021)

Cash flow quality index of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2021. Historical Cash Flow Quality Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Oncosem Onkolojik Sistemler Sanayi ve Ti cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Quality Index by Year (2020–2021)

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. cash flow quality index by year from 2020 to 2021. Year-by-year earnings quality comparison for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For the full cash flow conversion analysis, see Oncosem Onkolojik Sistemler Sanayi ve Ti cash conversion from operations.

Year Quality Index Operating CF (TRY) Net Income YoY Change
2021 0.72x TL51.68 Million TL71.73 Million ▼ -30.3%
2020 1.03x TL19.41 Million TL18.77 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.